Life Quality and Mental State in Patients With Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Other: Individualized complementary medicine treatmentOther: Individualized usual care
- Registration Number
- NCT01458457
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
Randomized pragmatic trial to evaluate the comparative effectiveness regarding disease specific quality of life of an individualized additional complementary medicine treatment in addition to usual care with usual care only in 280 women with breast cancer
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 275
- diagnosed breast cancer
- current usual care treatment
- willing to refrain from complementary treatment for 6 months in case of randomization into the usual care group
- informed consent
- complementary treatment at the Hospital Meran in the last 6 months
- no German or Italian language ability
- participation in other study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Usual Care + Complementary Medicine Individualized complementary medicine treatment - Usual care Individualized usual care - Usual Care + Complementary Medicine Individualized usual care -
- Primary Outcome Measures
Name Time Method Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B) 6 months
- Secondary Outcome Measures
Name Time Method Satisfaction and patient-reported effectiveness 3, 6 months This will only be assessed in the complementary medicine arm
Survival 6 months Functional Assessment of Chronic Illness Therapy-Fatigue 3, 6 months Functional Assessment of Cancer Therapy-Breast quality of life instrument (FACT-B) 3 months Subscale for Breast Cancer of the Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B) 3, 6 months Subscales of the Functional Assessment of Cancer Therapy - General (FACT-G): physical well-being, social/family well-being, emotional well-being, functional well-being) 3, 6 months Used complementary Therapies and their frequency 6 months This will only be assessed in the complementary medicine arm
Pain, quality of sleep, and nausea (single items of the FACT-B) 3, 6 months Survival without relapse 6 months Quality of Life (SF-12 Health Survey) 3, 6 months Undesirable Effects and Interactions 6 months Goal Attainment Scale 3 months This outcome measures will only be assessed in the complementary medicine arm
Expectations at Baseline Baseline This will only be assessed in the complementary medicine group
Trial Locations
- Locations (1)
Meran Hospital - Dienst fuer Komplementaermedizin
🇮🇹Meran, Italy